SNDX fund manager activity
Syndax Pharmaceuticals, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q4 2020 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | Sold out | — | — | 0.00% | Feb 17, 2026 |
| Torray Funds | New | 97,802 | $2,054,820 | 0.29% | Jan 28, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | New | 48,246 | $742,265 | 0.00% | Nov 14, 2025 |